Aydin, K. Et Al. 2016. Chemerin is not associated with subclinical atherosclerosis markers in prediabetes and diabetes. ANATOLIAN JOURNAL OF CARDIOLOGY , vol.16, no.10 , 749-755.

Aydin, K., CANPOLAT, U., Akin, S., Dural, M., Karakaya, J., AYTEMİR, K., ... ÖZER, N.(2016). Chemerin is not associated with subclinical atherosclerosis markers in prediabetes and diabetes. ANATOLIAN JOURNAL OF CARDIOLOGY , vol.16, no.10, 749-755.

Aydin, Kadriye Et Al. "Chemerin is not associated with subclinical atherosclerosis markers in prediabetes and diabetes," ANATOLIAN JOURNAL OF CARDIOLOGY , vol.16, no.10, 749-755, 2016

Aydin, Kadriye Et Al. "Chemerin is not associated with subclinical atherosclerosis markers in prediabetes and diabetes." ANATOLIAN JOURNAL OF CARDIOLOGY , vol.16, no.10, pp.749-755, 2016

Aydin, K. Et Al. (2016) . "Chemerin is not associated with subclinical atherosclerosis markers in prediabetes and diabetes." ANATOLIAN JOURNAL OF CARDIOLOGY , vol.16, no.10, pp.749-755.

@article{article, author={Kadriye Aydin Et Al. }, title={Chemerin is not associated with subclinical atherosclerosis markers in prediabetes and diabetes}, journal={ANATOLIAN JOURNAL OF CARDIOLOGY}, year=2016, pages={749-755} }